Preclinical Results Of Geovax's AIDS Vaccines Demonstrate Potential To Protect Against Disease

... GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company, have reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome ("AIDS") in non-human primates. [click link for full article] ...